Nucor Corp. (0K9L)
London Exchange · UK · prices in USD · close of 19 Oct 2026
Key indicators
| Last close | USD 261.41 |
|---|---|
| 52-week range | 128.85 – 284.35 |
| Return, 1 month / 3 months | +5.5% / +13.4% |
| Return, 1 year / 3 years | +96.3% / +78.3% |
| Trend | Uptrend |
| RSI (14) | 61 |
| Volatility (1 year) | 32.0% |
| Worst drawdown (1 year) | -18.3% |
| Average daily value traded | 0.31M USD |
| Dividend yield | 0.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Nucor Corp. is a steel manufacturer based in the United States. It makes steel and steel products, including beams, sheet, bar and plate, using electric arc furnaces that melt recycled scrap. The company also produces steel joists, decking, fasteners and rebar, and it operates scrap processing and recycling businesses that supply its mills. Its customers are mainly in construction, infrastructure, automotive, energy and general manufacturing, and it serves markets across North America through a network of mills and fabrication plants.
The shares are listed on the London Exchange in UK under the code 0K9L, and the price on this page is in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Nucor Corp. (0K9L) trades on the London Exchange in UK. It last closed at USD 261.41 on 19 October 2026.
Its price-based Market X-Ray is 73 out of 100 (a strong price profile), ranking 323 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 96.3% and over the last three months it rose 13.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 86 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 20.0% | ||
| From 52-week high | -4.7% | ||
| Momentum | 89 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 13.4% | ||
| 6-month return | 36.6% | ||
| 12-month return, skipping the last month | 86.1% | ||
| Risk (lower is better) | 67 · Fair | Typical risk for this exchange. | |
| Volatility (1 year) | 32.0% | ||
| Worst drawdown (1 year) | -18.3% | ||
| Liquidity | 41 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.31M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 64 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 0.9% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +2.8% |
|---|---|
| 1 month | +5.5% |
| 3 months | +13.4% |
| 6 months | +36.6% |
| 1 year | +96.3% |
| 3 years | +78.3% |
| 5 years | – |
Signals
| 50-day / 200-day average | 253.95 / 217.93 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 11.03 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Sep 2026 | USD 0.5600 |
| 29 Jun 2026 | USD 0.5600 |
| 30 Mar 2026 | USD 0.5600 |
| 30 Dec 2025 | USD 0.5600 |
| 29 Sep 2025 | USD 0.5500 |
| 27 Jun 2025 | USD 0.5500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.